ciprofloxacin has been researched along with Corneal Diseases in 15 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Corneal Diseases: Diseases of the cornea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine how age affects the risk of developing a white corneal precipitate during ciprofloxacin therapy for bacterial keratitis and to explore the effect of a white precipitate on rates of clinical improvement and cure." | 7.72 | Corneal ciprofloxacin precipitation during bacterial keratitis. ( Abshire, RL; Wilhelmus, KR, 2003) |
| "To examine how age affects the risk of developing a white corneal precipitate during ciprofloxacin therapy for bacterial keratitis and to explore the effect of a white precipitate on rates of clinical improvement and cure." | 3.72 | Corneal ciprofloxacin precipitation during bacterial keratitis. ( Abshire, RL; Wilhelmus, KR, 2003) |
| " The purpose of this study is to compare corneal tissue ciprofloxacin levels in patients exposed to three ciprofloxacin dosing regimens before undergoing penetrating keratoplasty." | 2.68 | Corneal tissue levels of topically applied ciprofloxacin. ( Collins, KS; Gonzales, JS; Price, FW; Whitson, WE, 1995) |
| "Ciprofloxacin eye drops were immediately discontinued and replaced by topical artificial tear substitute and tobramycin eye drop along with prednisolone acetate." | 1.40 | Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery. ( Mahadik, S; Vijay Zawar, S, 2014) |
| "To investigate the concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea." | 1.35 | Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea. ( Anderson, S; Baddon, AC; Bamber, S; Dwyer, N; Kaye, SB; Lovering, AM; Neal, T; Nicholson, S; Seddon, K; Smith, G; Szkurlat, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mansour, AM | 1 |
| Mansour, HA | 1 |
| Vijay Zawar, S | 1 |
| Mahadik, S | 1 |
| El Mellaoui, M | 1 |
| Laktaoui, A | 1 |
| Elias, R | 1 |
| Mamani, J | 1 |
| Hermoza, C | 1 |
| Kinsella, J | 1 |
| Kaye, SB | 1 |
| Neal, T | 1 |
| Nicholson, S | 1 |
| Szkurlat, J | 1 |
| Bamber, S | 1 |
| Baddon, AC | 1 |
| Anderson, S | 1 |
| Seddon, K | 1 |
| Dwyer, N | 1 |
| Lovering, AM | 1 |
| Smith, G | 1 |
| Wilhelmus, KR | 1 |
| Abshire, RL | 2 |
| Patwardhan, A | 1 |
| Khan, M | 1 |
| Daniel, E | 1 |
| Brand, ME | 1 |
| Essepian, JP | 1 |
| Rajpal, R | 1 |
| O'Brien, TP | 1 |
| Price, FW | 1 |
| Whitson, WE | 1 |
| Collins, KS | 1 |
| Gonzales, JS | 1 |
| Macsai, MS | 1 |
| Goel, AK | 1 |
| Michael, MM | 1 |
| Wall, GM | 1 |
| Sternitzke, KD | 1 |
| McElvanney, AM | 1 |
| Bernardino, CR | 1 |
| Rapuano, C | 1 |
| Sridhar, MS | 1 |
| Sharma, S | 1 |
| Garg, P | 1 |
| Rao, GN | 1 |
| Stevens, SX | 1 |
| Fouraker, BD | 1 |
| Jensen, HG | 1 |
1 trial available for ciprofloxacin and Corneal Diseases
| Article | Year |
|---|---|
Corneal tissue levels of topically applied ciprofloxacin.
Topics: Administration, Topical; Chromatography, High Pressure Liquid; Ciprofloxacin; Cornea; Corneal Diseas | 1995 |
14 other studies available for ciprofloxacin and Corneal Diseases
| Article | Year |
|---|---|
Reversible postoperative visual loss from ciprofloxacin corneal deposit.
Topics: Anti-Bacterial Agents; Blindness; Ciprofloxacin; Corneal Diseases; Humans; Ophthalmic Solutions; Pos | 2019 |
Corneal deposit after topical ciprofloxacin as postoperative medication after cataract surgery.
Topics: Administration, Topical; Aged; Anti-Bacterial Agents; Cataract Extraction; Chemical Precipitation; C | 2014 |
Corneal plates of fluoroquinolone.
Topics: Ciprofloxacin; Cornea; Corneal Diseases; Crystallization; Humans; Male; Middle Aged | 2014 |
First report of thelaziosis (Thelazia anolabiata) in an Andean Cock of the Rock (Rupicola peruviana) from Peru.
Topics: Animals; Anthelmintics; Anti-Bacterial Agents; Bird Diseases; Ciprofloxacin; Corneal Diseases; Iverm | 2008 |
Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Biological Availability; Ciprofloxacin; Cornea; Corne | 2009 |
Corneal ciprofloxacin precipitation during bacterial keratitis.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Infective Agents; Chemical Precipitation; Child; Ciproflo | 2003 |
Topical ciprofloxacin can delay recovery from viral ocular surface infection.
Topics: Adenoviridae Infections; Administration, Topical; Anti-Infective Agents; Ciprofloxacin; Corneal Dise | 2005 |
An unusual presentation of recurrent corneal abrasion in a lepromatous patient with impaired corneal sensation.
Topics: Anti-Infective Agents; Atropine; Ciprofloxacin; Cornea; Corneal Diseases; Corneal Injuries; Humans; | 1995 |
Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo.
Topics: Administration, Topical; Animals; Calcinosis; Chemical Precipitation; Ciprofloxacin; Cornea; Corneal | 1995 |
Deposition of ciprofloxacin, prednisolone phosphate, and prednisolone acetate in SeeQuence disposable contact lenses.
Topics: Aged; Ciprofloxacin; Contact Lenses, Hydrophilic; Corneal Diseases; Crystallization; Disposable Equi | 1993 |
Hypopyon keratitis in corneal epithelial basement membrane dystrophy.
Topics: Adult; Anti-Infective Agents; Bacterial Infections; Basement Membrane; Ciprofloxacin; Corneal Diseas | 1999 |
Ophthalmia nodosa caused by casual handling of a tarantula.
Topics: Adult; Animals; Ciprofloxacin; Conjunctiva; Conjunctival Diseases; Cornea; Corneal Diseases; Corneal | 2000 |
Epithelial infectious crystalline keratopathy.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Corneal Diseases; Corynebacterium Infections; Epitheliu | 2001 |
Intraocular safety of ciprofloxacin.
Topics: Animals; Anterior Chamber; Ciprofloxacin; Corneal Diseases; Eye; Lens, Crystalline; Punctures; Rabbi | 1991 |